Gorjan Hrustanovic, PhD

Dr. Gorjan Hrustanovic is Managing Director at BVF Partners L.P., where he focuses on biotech and therapeutic investments. Gorjan is currently serving on the board of Rain Therapeutics, Inc., Olema Pharmaceuticals, Inc, and is also a board observer at 4D Molecular Therapeutics.

Prior to joining BVF in 2015, Gorjan received his PhD in Cancer Biology & Cell Signaling at the University of California, San Francisco (UCSF), where he also co-founded a small biotech-focused investment fund. At UCSF, his research focus was personalized medicine and molecularly targeted therapy in non-small cell lung cancer. His research in cancer biology is published in peer-reviewed journals such as Nature Medicine, Oncogene, Cell Reports, and others. Gorjan earned his BS degree in Molecular Biology, and a BS in Economics/Management Science from UCSD.